Puliani, Giulia
Sbardella, Emilia
Cozzolino, Alessia
Sada, Valentina
Tozzi, Rossella
Andreoli, Chiara
Fiorelli, Marco
Di Biasi, Claudio
Corallino, Diletta
Balla, Andrea http://orcid.org/0000-0002-0182-8761
Paganini, Alessandro M. http://orcid.org/0000-0003-1821-005X
Venneri, Mary Anna
Lenzi, Andrea
Lubrano, Carla http://orcid.org/0000-0001-8261-1451
Isidori, Andrea M. http://orcid.org/0000-0002-9037-5417
Article History
Received: 5 August 2022
Revised: 18 June 2023
Accepted: 4 July 2023
First Online: 21 July 2023
Change Date: 28 August 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41366-023-01363-9
Competing interests
: GP, ES, AC, VS, CA, MF, GG, DC, AB, AMP, MAV, AL, and CL have nothing to disclose. AMI has served as a consultant for Novartis, Takeda, Recordati, and Sandoz companies, has received unconditional research grants from Shire, IPSEN, and Pfizer.